Alps Advisors Inc Protagonist Therapeutics, Inc Transaction History

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

A detailed history of Alps Advisors Inc transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Alps Advisors Inc holds 45,772 shares of PTGX stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,772
Previous 41,099 11.37%
Holding current value
$2.18 Million
Previous $1.19 Million 33.42%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$24.66 - $34.8 $115,236 - $162,620
4,673 Added 11.37%
45,772 $1.59 Million
Q1 2024

May 14, 2024
BUY
$21.79 - $32.15 $22,378 - $33,018
1,027 Added 2.56%
41,099 $1.19 Million
Q4 2023

Feb 14, 2024
SELL
$14.05 - $23.44 $33,396 - $55,716
-2,377 Reduced 5.6%
40,072 $918,000
Q3 2023

Nov 14, 2023
BUY
$16.68 - $23.66 $6,138 - $8,706
368 Added 0.87%
42,449 $708,000
Q2 2023

Aug 14, 2023
BUY
$18.02 - $29.36 $174,181 - $283,793
9,666 Added 29.82%
42,081 $1.16 Million
Q1 2023

May 10, 2023
SELL
$10.78 - $25.38 $10,068 - $23,704
-934 Reduced 2.8%
32,415 $745,000
Q4 2022

Feb 14, 2023
BUY
$7.36 - $11.17 $48,046 - $72,917
6,528 Added 24.34%
33,349 $363,000
Q3 2022

Nov 14, 2022
SELL
$7.86 - $11.71 $16,097 - $23,982
-2,048 Reduced 7.09%
26,821 $226,000
Q2 2022

Aug 11, 2022
SELL
$7.06 - $25.52 $147,490 - $533,138
-20,891 Reduced 41.98%
28,869 $228,000
Q1 2022

May 16, 2022
SELL
$23.34 - $36.08 $127,716 - $197,429
-5,472 Reduced 9.91%
49,760 $1.18 Million
Q4 2021

Feb 09, 2022
BUY
$17.63 - $37.1 $573,644 - $1.21 Million
32,538 Added 143.38%
55,232 $1.89 Million
Q2 2018

Jul 25, 2018
SELL
$5.99 - $9.1 $28,596 - $43,443
-4,774 Reduced 17.38%
22,694 $472,000
Q1 2018

May 01, 2018
BUY
$8.46 - $23.08 $40,388 - $110,183
4,774 Added 21.04%
27,468 $236,000
Q4 2017

Feb 05, 2018
BUY
$14.47 - $20.8 $328,382 - $472,035
22,694
22,694 $472,000

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.34B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email